{"investor":{"slug":"third-rock-ventures","name":"Third Rock Ventures","website":null,"x_handle":null,"logo":null,"type":"fund","companies":1,"deals":2,"deals_12m":0,"leads":0,"round_capital":325000000,"latest_deal":{"date":"2024-10-21","stage":"series-b+","amount_usd":225000000,"company":{"slug":"seaport-therapeutics-2","name":"Seaport Therapeutics"}}},"profile":null,"fund_returns":[],"portfolio":[{"slug":"seaport-therapeutics-2","name":"Seaport Therapeutics","logo":"https://recentfunding.com/logo/u/aHR0cHM6Ly9wYnMudHdpbWcuY29tL3Byb2ZpbGVfaW1hZ2VzLzE3NzM0MTI4NjY2ODQ2MDAzMjAvZUdFMnF2X3FfNDAweDQwMC5wbmc","crypto":false,"categories":["health-bio"],"total_raised":325000000,"latest_raise":{"date":"2024-10-21","stage":"series-b+","amount_usd":225000000,"source_url":"https://seaporttx.com/press-release/seaport-therapeutics-closes-225-million-oversubscribed-series-b-financing-round/"},"rounds_with_investor":[{"date":"2024-10-21","stage":"series-b+","amount_usd":225000000,"source_url":"https://seaporttx.com/press-release/seaport-therapeutics-closes-225-million-oversubscribed-series-b-financing-round/","lead":false},{"date":"2024-04-09","stage":"series-a","amount_usd":100000000,"source_url":"https://seaporttx.com/press-release/seaport-therapeutics-launches-with-100-million-oversubscribed-series-a-financing-round-to-advance-novel-neuropsychiatric-medicines/","lead":false}]}],"top_categories":[{"key":"health-bio","label":"Health and bio","companies":1,"share":1}],"allocation":{"stages":[{"key":"series-a","label":"Series a","deals":1,"capital":100000000,"share":0.5},{"key":"series-b+","label":"Series b+","deals":1,"capital":225000000,"share":0.5}],"years":[{"year":"2024","deals":2,"capital":325000000,"share":1}]},"co_investors":[{"slug":"arch-venture-partners","name":"ARCH Venture Partners","logo":null,"type":"fund","shared_rounds":2,"last_shared":"2024-10-21"},{"slug":"sofinnova-investments","name":"Sofinnova Investments","logo":null,"type":"fund","shared_rounds":2,"last_shared":"2024-10-21"},{"slug":"puretech-health","name":"PureTech Health","logo":null,"type":"fund","shared_rounds":2,"last_shared":"2024-10-21"},{"slug":"t-rowe-price","name":"T. Rowe Price","logo":null,"type":"fund","shared_rounds":1,"last_shared":"2024-10-21"},{"slug":"general-atlantic","name":"General Atlantic","logo":"https://recentfunding.com/logo/d/generalatlantic.com.png","type":"fund","shared_rounds":1,"last_shared":"2024-10-21"},{"slug":"cpp-investments","name":"CPP Investments","logo":null,"type":"fund","shared_rounds":1,"last_shared":"2024-10-21"},{"slug":"invus","name":"Invus","logo":null,"type":"fund","shared_rounds":1,"last_shared":"2024-10-21"},{"slug":"goldman-sachs-alternatives","name":"Goldman Sachs Alternatives","logo":null,"type":"fund","shared_rounds":1,"last_shared":"2024-10-21"},{"slug":"foresite-capital","name":"Foresite Capital","logo":null,"type":"fund","shared_rounds":1,"last_shared":"2024-10-21"}]}